SAN FRANCISCO, CA / ACCESS Newswire / / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that Magdalena ...

In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...

Researchers claim to have developed a new compound that boosts metabolism and improves blood sugar levels, an advance they say could lead to weight-loss pills that don’t carry the side effects of ...

Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...

Millions of patients taking GLP-1 receptor agonists such as semaglutide have achieved dramatic weight loss, but a growing ...

Certain foods can naturally reduce appetite and slow down gastric emptying by stimulating the release of GLP-1 and other ...

A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce ...

The study found that a significant portion of patients who discontinued the drug actually went back to treatment within a ...

Pfizer's experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said ...

People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs. But diet and ...

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.